$CLBZ

Collab Z Inc.

CIK:0002050338|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2026	Mar. 31, 2025	Mar. 31, 2026	Mar. 31, 2025
Income Statement [Abstract]
Revenue - related parties	$ 392,777	$ 295,769	$ 776,373	$ 525,636
Revenue	386,172	82,549	485,819	282,549
Total revenue	778,949	378,318	1,262,192	808,185
Cost of revenue	119,941	103,147	197,308	185,957
Gross profit	659,008	275,171	1,064,884	622,228
Operating expenses:
Sales and marketing	141,881	5,722	201,801	10,248
General and administrative	335,977	244,764	597,814	466,555
Total operating expenses	477,858	250,486	799,615	476,803
Income from operations	181,150	24,685	265,269	145,425
Other income (expense)
Interest income	13,828	17,351	22,183	17,351
Interest expense		(14,296)		(23,006)
Loss on joint ventures	(2,754)		(516)
Other income		113		1,418
Total other income (expense)	11,074	3,168	21,667	(4,237)
Provision for income taxes
Net income	$ 192,224	$ 27,853	$ 286,936	$ 141,188
Weighted average common shares outstanding
Basic	5,091,391	5,091,391	5,091,391	5,091,391
Diluted	5,091,391	5,091,391	5,091,391	5,091,391
Net income per common share
Basic	$ 0.03	$ 0.01	$ 0.04	$ 0.03
Diluted	$ 0.03	$ 0.01	$ 0.04	$ 0.03

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net Income (Loss)	$ 286,936	$ 141,188
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization	26,667	26,667
Loss on joint ventures	516
Non-cash equity contributions	20,000	16,000
Changes in operating assets and liabilities:
Accounts receivable - related parties	(319,647)	(182,618)
Accounts receivable	(402,712)	130,232
Prepaid expenses	8,346	(42,508)
Interest receivable	(12,608)
Accounts payable and accrued expenses	121,485	32,835
Deferred revenue		7,000
Net cash (used in) provided by operating activities	(271,017)	128,796
Cash flows from investing activities:
Due from related parties, net of repayment	(37,001)	2,065,199
Capitalized software development	(129,993)	(19,500)
Issuance of loan receivable		(1,470,000)
Repayments of loan receivable	250,000	662,275
Net cash provided by investing activities	83,006	1,237,974
Cash flows from financing activities:
Due to related parties, net of repayment	13,396	(631,833)
Proceeds from line of credit		1,300,000
Repayment of line of credit		(1,942,854)
Subscription receivable	150,000	0
Deferred offering costs	(100,839)	(148,392)
Issuance of Series C preferred stock	2,753,000
Dividend paid	(15,683)
Net cash provided by (used in) financing activities	2,799,874	(1,423,079)
Net change in cash	2,611,863	(56,309)
Cash and restricted cash at beginning of period	161,506	105,034
Cash and restricted cash at end of period	2,773,369	48,725
Reconciliation of cash and restricted cash:
Cash at beginning of period	161,506	105,034
Restricted cash at beginning of period
Cash and restricted cash at beginning of period	161,506	105,034
Cash at end of period	10,794	48,725
Restricted cash at end of period	2,762,575
Cash and restricted cash at end of period	2,773,369	48,725
Supplemental disclosure of cash flow information:
Cash paid for income taxes
Cash paid for interest		22,352
Supplemental disclosure of non-cash investing and financing activities:
Preferred stock dividends included in mezzanine equity	39,615
Shares issued pursuant to investment in joint venture		20,000
Deferred offering costs included in accrued expenses		$ 175,000

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2026	Sep. 30, 2025
Current assets:
Cash	$ 10,794	$ 161,506
Restricted cash	2,762,575
Accounts receivable	489,684	86,972
Due from related parties	420,578	383,577
Prepaid expenses and other current assets	5,587	13,933
Subscription receivable		150,000
Loan receivable	314,668	552,059
Total current assets	4,590,113	1,614,627
Deferred offering costs	720,764	619,925
Investment in joint venture	57,237	57,753
Intangible assets, net	301,504	198,178
Total assets	5,669,618	2,490,483
Current liabilities:
Accounts payable and accrued expenses	498,447	376,961
Deferred revenue	35,000	35,000
Due to related parties	30,001	16,605
Dividend payable	25,577
Total current liabilities	589,025	428,566
Future equity obligations	25,000	25,000
Total liabilities	614,025	453,566
Commitments and contingencies (Note 11)
Mezzanine equity:
Common stock subject to possible redemption, $0.001 par value, 60,000 shares issued and outstanding as of both March 31, 2026 and September 30, 2025, respectively	120,000	120,000
Redeemable convertible preferred stock, $0.001 par value, 10,000,000 shares authorized, 1,250,000 designated as Series C; 688,250 and 0 shares issued and outstanding as of March 31, 2026 and September 30, 2025, respectively	2,792,615
Stockholders’ equity:
Common stock, $0.001 par value, 190,000,000 shares authorized, 5,091,391 shares issued and outstanding as of both March 31, 2026 and September 30, 2025	5,092	5,092
Additional paid-in capital	1,164,513	1,144,513
Retained earnings	973,168	767,107
Total stockholders’ equity	2,142,978	1,916,917
Total liabilities, mezzanine equity and stockholders’ equity	5,669,618	2,490,483
Related Parties
Current assets:
Accounts receivable - related parties	586,227	266,580
Series B
Stockholders’ equity:
Preferred stock value	200	200
Series X
Stockholders’ equity:
Preferred stock value	$ 5	$ 5